These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 11070182)
1. (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. Morley KC; McGregor IS Eur J Pharmacol; 2000 Nov; 408(1):41-9. PubMed ID: 11070182 [TBL] [Abstract][Full Text] [Related]
2. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Morley KC; Arnold JC; McGregor IS Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091 [TBL] [Abstract][Full Text] [Related]
3. Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala. Navarro JF; Rivera A; Maldonado E; Cavas M; de la Calle A Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):249-54. PubMed ID: 14751419 [TBL] [Abstract][Full Text] [Related]
5. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Thompson MR; Li KM; Clemens KJ; Gurtman CG; Hunt GE; Cornish JL; McGregor IS Neuropsychopharmacology; 2004 Apr; 29(4):694-704. PubMed ID: 14627999 [TBL] [Abstract][Full Text] [Related]
6. Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze. Navarro JF; Maldonado E Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1151-4. PubMed ID: 12452538 [TBL] [Abstract][Full Text] [Related]
7. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Gurtman CG; Morley KC; Li KM; Hunt GE; McGregor IS Eur J Pharmacol; 2002 Jun; 446(1-3):89-96. PubMed ID: 12098589 [TBL] [Abstract][Full Text] [Related]
8. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Ho YJ; Pawlak CR; Guo L; Schwarting RK Behav Brain Res; 2004 Mar; 149(2):135-44. PubMed ID: 15129777 [TBL] [Abstract][Full Text] [Related]
9. A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy"). Thompson MR; Callaghan PD; Hunt GE; Cornish JL; McGregor IS Neuroscience; 2007 May; 146(2):509-14. PubMed ID: 17383105 [TBL] [Abstract][Full Text] [Related]
10. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues. Quinteros-Muñoz D; Sáez-Briones P; Díaz-Véliz G; Mora-Gutiérrez S; Rebolledo-Fuentes M; Cassels BK Behav Neurosci; 2010 Oct; 124(5):662-76. PubMed ID: 20939666 [TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats. Palenicek T; Votava M; Bubenikova V; Horacek J Physiol Behav; 2005 Nov; 86(4):546-53. PubMed ID: 16233904 [TBL] [Abstract][Full Text] [Related]
12. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443 [TBL] [Abstract][Full Text] [Related]
13. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. Bull EJ; Hutson PH; Fone KC Neuropharmacology; 2004 Feb; 46(2):202-10. PubMed ID: 14680758 [TBL] [Abstract][Full Text] [Related]
14. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats. Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566 [TBL] [Abstract][Full Text] [Related]
15. Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box. Maldonado E; Navarro JF Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):463-72. PubMed ID: 10836493 [TBL] [Abstract][Full Text] [Related]
16. Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Ramos L; Hicks C; Kevin R; Caminer A; Narlawar R; Kassiou M; McGregor IS Neuropsychopharmacology; 2013 Oct; 38(11):2249-59. PubMed ID: 23676791 [TBL] [Abstract][Full Text] [Related]
17. Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Ramos L; Hicks C; Caminer A; Goodwin J; McGregor IS Psychopharmacology (Berl); 2015 Jul; 232(14):2631-41. PubMed ID: 25772337 [TBL] [Abstract][Full Text] [Related]
18. The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine. Lin HQ; Burden PM; Christie MJ; Johnston GA Pharmacol Biochem Behav; 1999 Mar; 62(3):403-8. PubMed ID: 10080230 [TBL] [Abstract][Full Text] [Related]
19. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). Morley KC; Gallate JE; Hunt GE; Mallet PE; McGregor IS Eur J Pharmacol; 2001 Dec; 433(1):91-9. PubMed ID: 11755138 [TBL] [Abstract][Full Text] [Related]
20. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats. Schindler CW; Thorndike EB; Blough BE; Tella SR; Goldberg SR; Baumann MH Br J Pharmacol; 2014 Jan; 171(1):83-91. PubMed ID: 24328722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]